얼굴용 주사제 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2035년)

Facial Injectables Market - Scope of Report

TMR's report on the global facial injectables market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global facial injectables market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global facial injectables market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the facial injectables market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global facial injectables market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global facial injectables market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global facial injectables market.

The report delves into the competitive landscape of the global facial injectables market. Key players operating in the global facial injectables market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global facial injectables market profiled in this report.

Key Questions Answered in Global facial injectables market Report:

• What are the opportunities in the global facial injectables market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2035?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Facial Injectables Market - Research Objectives and Research Approach

The comprehensive report on the global facial injectables market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global facial injectables market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global facial injectables market.

Table of Contents

1. Preface

• 1.1. Market Definition and Scope
• 1.2. Market Segmentation
• 1.3. Key Research Objectives
• 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Facial Injectables Market

4. Market Overview

• 4.1. Introduction
  • 4.1.1. Segment Definition
• 4.2. Overview
• 4.3. Market Dynamics
  • 4.3.1. Drivers
  • 4.3.2. Restraints
  • 4.3.3. Opportunities
• 4.4. Global Facial Injectables Market Analysis and Forecast, 2020 to 2035
  • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

• 5.1. Key Industry Events (Partnerships, Collaborations, Product approvals, Mergers & Acquisitions)
• 5.2. Product/Brand Analysis
• 5.3. Pricing Analysis
• 5.4. Technological Advancements
• 5.5. PESTEL Analysis
• 5.6. Regulatory Scenario by Key Countries/Regions
• 5.7. Porter's Five Forces Analysis
• 5.8. Reimbursement Scenario by Key Countries
• 5.9. Key Purchase Metrics for End-users
• 5.10. Go-to-Market Strategy for New Market Entrants

6. Global Facial Injectables Market Analysis and Forecast, by Product Type

• 6.1. Introduction & Definition
• 6.2. Key Findings/Developments
• 6.3. Market Value Forecast, by Product Type, 2020 to 2035
  • 6.3.1. Dermal Fillers
    • 6.3.1.1. Hyaluronic acid (HA)
    • 6.3.1.2. Calcium hydroxylapatite (CaHA)
    • 6.3.1.3. Poly-L-lactic acid (PLLA)
    • 6.3.1.4. Polymethylmethacrylate (PMMA)
    • 6.3.1.5. Others
  • 6.3.2. Botulinum Toxin
  • 6.3.3. Platelet-Rich Plasma (PRP)
  • 6.3.4. Deoxycholic Acid
  • 6.3.5. Others
• 6.4. Market Attractiveness Analysis, by Product Type

7. Global Facial Injectables Market Analysis and Forecast, by Gender

• 7.1. Introduction & Definition
• 7.2. Key Findings/Developments
• 7.3. Market Value Forecast, by Gender, 2020 to 2035
  • 7.3.1. Male
  • 7.3.2. Female
• 7.4. Market Attractiveness Analysis, by Gender

8. Global Facial Injectables Market Analysis and Forecast, by Application

• 8.1. Introduction & Definition
• 8.2. Key Findings/Developments
• 8.3. Market Value Forecast, by Application, 2020 to 2035
  • 8.3.1. Facial Line Correction
  • 8.3.2. Lip Augmentation
  • 8.3.3. Scar Treatment
  • 8.3.4. Face Lift
  • 8.3.5. Facial Volume Enhancement
  • 8.3.6. Others
• 8.4. Market Attractiveness Analysis, by Application

9. Global Facial Injectables Market Analysis and Forecast, by End-user

• 9.1. Introduction & Definition
• 9.2. Key Findings/Developments
• 9.3. Market Value Forecast, by End-user, 2020 to 2035
  • 9.3.1. Hospitals
  • 9.3.2. Dermatology Clinics
  • 9.3.3. MedSpas
  • 9.3.4. Others
• 9.4. Market Attractiveness Analysis, by End-user

10. Global Facial Injectables Market Analysis and Forecast, by Region

• 10.1. Key Findings
• 10.2. Market Value Forecast, by Region, 2020 to 2035
  • 10.2.1. North America
  • 10.2.2. Europe
  • 10.2.3. Asia Pacific
  • 10.2.4. Latin America
  • 10.2.5. Middle East & Africa
• 10.3. Market Attractiveness By Region

11. North America Facial Injectables Market Analysis and Forecast

• 11.1. Introduction
  • 11.1.1. Key Findings
• 11.2. Market Value Forecast, by Product Type, 2020 to 2035
  • 11.2.1. Dermal Fillers
    • 11.2.1.1. Hyaluronic acid (HA)
    • 11.2.1.2. Calcium hydroxylapatite (CaHA)
    • 11.2.1.3. Poly-L-lactic acid (PLLA)
    • 11.2.1.4. Polymethylmethacrylate (PMMA)
    • 11.2.1.5. Others
  • 11.2.2. Botulinum Toxin
  • 11.2.3. Platelet-Rich Plasma (PRP)
  • 11.2.4. Deoxycholic Acid
  • 11.2.5. Others
• 11.3. Market Value Forecast, by Gender, 2020 to 2035
  • 11.3.1. Male
  • 11.3.2. Female
• 11.4. Market Value Forecast, by Application, 2020 to 2035
  • 11.4.1. Facial Line Correction
  • 11.4.2. Lip Augmentation
  • 11.4.3. Scar Treatment
  • 11.4.4. Face Lift
  • 11.4.5. Facial Volume Enhancement
  • 11.4.6. Others
• 11.5. Market Value Forecast, by End-user, 2020 to 2035
  • 11.5.1. Hospitals
  • 11.5.2. Dermatology Clinics
  • 11.5.3. MedSpas
  • 11.5.4. Others
• 11.6. Market Value Forecast, by Country, 2020 to 2035
  • 11.6.1. U.S.
  • 11.6.2. Canada
• 11.7. Market Attractiveness Analysis
  • 11.7.1. By Product Type
  • 11.7.2. By Gender
  • 11.7.3. By Application
  • 11.7.4. By End-user
  • 11.7.5. By Country

12. Europe Facial Injectables Market Analysis and Forecast

• 12.1. Introduction
  • 12.1.1. Key Findings
• 12.2. Market Value Forecast, by Product Type, 2020 to 2035
  • 12.2.1. Dermal Fillers
    • 12.2.1.1. Hyaluronic acid (HA)
    • 12.2.1.2. Calcium hydroxylapatite (CaHA)
    • 12.2.1.3. Poly-L-lactic acid (PLLA)
    • 12.2.1.4. Polymethylmethacrylate (PMMA)
    • 12.2.1.5. Others
  • 12.2.2. Botulinum Toxin
  • 12.2.3. Platelet-Rich Plasma (PRP)
  • 12.2.4. Deoxycholic Acid
  • 12.2.5. Others
• 12.3. Market Value Forecast, by Gender, 2020 to 2035
  • 12.3.1. Male
  • 12.3.2. Female
• 12.4. Market Value Forecast, by Application, 2020 to 2035
  • 12.4.1. Facial Line Correction
  • 12.4.2. Lip Augmentation
  • 12.4.3. Scar Treatment
  • 12.4.4. Face Lift
  • 12.4.5. Facial Volume Enhancement
  • 12.4.6. Others
• 12.5. Market Value Forecast, by End-user, 2020 to 2035
  • 12.5.1. Hospitals
  • 12.5.2. Dermatology Clinics
  • 12.5.3. MedSpas
  • 12.5.4. Others
• 12.6. Market Value Forecast, by Country/Sub-region, 2020 to 2035
  • 12.6.1. Germany
  • 12.6.2. UK
  • 12.6.3. France
  • 12.6.4. Italy
  • 12.6.5. Spain
  • 12.6.6. Rest of Europe
• 12.7. Market Attractiveness Analysis
  • 12.7.1. By Product Type
  • 12.7.2. By Gender
  • 12.7.3. By Application
  • 12.7.4. By End-user
  • 12.7.5. By Country/Sub-region

13. Asia Pacific Facial Injectables Market Analysis and Forecast

• 13.1. Introduction
  • 13.1.1. Key Findings
• 13.2. Market Value Forecast, by Product Type, 2020 to 2035
  • 13.2.1. Dermal Fillers
    • 13.2.1.1. Hyaluronic acid (HA)
    • 13.2.1.2. Calcium hydroxylapatite (CaHA)
    • 13.2.1.3. Poly-L-lactic acid (PLLA)
    • 13.2.1.4. Polymethylmethacrylate (PMMA)
    • 13.2.1.5. Others
  • 13.2.2. Botulinum Toxin
  • 13.2.3. Platelet-Rich Plasma (PRP)
  • 13.2.4. Deoxycholic Acid
  • 13.2.5. Others
• 13.3. Market Value Forecast, by Gender, 2020 to 2035
  • 13.3.1. Male
  • 13.3.2. Female
• 13.4. Market Value Forecast, by Application, 2020 to 2035
  • 13.4.1. Facial Line Correction
  • 13.4.2. Lip Augmentation
  • 13.4.3. Scar Treatment
  • 13.4.4. Face Lift
  • 13.4.5. Facial Volume Enhancement
  • 13.4.6. Others
• 13.5. Market Value Forecast, by End-user, 2020 to 2035
  • 13.5.1. Hospitals
  • 13.5.2. Dermatology Clinics
  • 13.5.3. MedSpas
  • 13.5.4. Others
• 13.6. Market Value Forecast, by Country/Sub-region, 2020 to 2035
  • 13.6.1. China
  • 13.6.2. Japan
  • 13.6.3. India
  • 13.6.4. Australia & New Zealand
  • 13.6.5. Rest of Asia Pacific
• 13.7. Market Attractiveness Analysis
  • 13.7.1. By Product Type
  • 13.7.2. By Gender
  • 13.7.3. By Application
  • 13.7.4. By End-user
  • 13.7.5. By Country/Sub-region

14. Latin America Facial Injectables Market Analysis and Forecast

• 14.1. Introduction
  • 14.1.1. Key Findings
• 14.2. Market Value Forecast, by Product Type, 2020 to 2035
  • 14.2.1. Dermal Fillers
    • 14.2.1.1. Hyaluronic acid (HA)
    • 14.2.1.2. Calcium hydroxylapatite (CaHA)
    • 14.2.1.3. Poly-L-lactic acid (PLLA)
    • 14.2.1.4. Polymethylmethacrylate (PMMA)
    • 14.2.1.5. Others
  • 14.2.2. Botulinum Toxin
  • 14.2.3. Platelet-Rich Plasma (PRP)
  • 14.2.4. Deoxycholic Acid
  • 14.2.5. Others
• 14.3. Market Value Forecast, by Gender, 2020 to 2035
  • 14.3.1. Male
  • 14.3.2. Female
• 14.4. Market Value Forecast, by Application, 2020 to 2035
  • 14.4.1. Facial Line Correction
  • 14.4.2. Lip Augmentation
  • 14.4.3. Scar Treatment
  • 14.4.4. Face Lift
  • 14.4.5. Facial Volume Enhancement
  • 14.4.6. Others
• 14.5. Market Value Forecast, by End-user, 2020 to 2035
  • 14.5.1. Hospitals
  • 14.5.2. Dermatology Clinics
  • 14.5.3. MedSpas
  • 14.5.4. Others
• 14.6. Market Value Forecast, by Country/Sub-region, 2020 to 2035
  • 14.6.1. Brazil
  • 14.6.2. Mexico
  • 14.6.3. Rest of Latin America
• 14.7. Market Attractiveness Analysis
  • 14.7.1. By Product Type
  • 14.7.2. By Gender
  • 14.7.3. By Application
  • 14.7.4. By End-user
  • 14.7.5. By Country/Sub-region

15. Middle East & Africa Facial Injectables Market Analysis and Forecast

• 15.1. Introduction
  • 15.1.1. Key Findings
• 15.2. Market Value Forecast, by Product Type, 2020 to 2035
  • 15.2.1. Dermal Fillers
    • 15.2.1.1. Hyaluronic acid (HA)
    • 15.2.1.2. Calcium hydroxylapatite (CaHA)
    • 15.2.1.3. Poly-L-lactic acid (PLLA)
    • 15.2.1.4. Polymethylmethacrylate (PMMA)
    • 15.2.1.5. Others
  • 15.2.2. Botulinum Toxin
  • 15.2.3. Platelet-Rich Plasma (PRP)
  • 15.2.4. Deoxycholic Acid
  • 15.2.5. Others
• 15.3. Market Value Forecast, by Gender, 2020 to 2035
  • 15.3.1. Male
  • 15.3.2. Female
• 15.4. Market Value Forecast, by Application, 2020 to 2035
  • 15.4.1. Facial Line Correction
  • 15.4.2. Lip Augmentation
  • 15.4.3. Scar Treatment
  • 15.4.4. Face Lift
  • 15.4.5. Facial Volume Enhancement
  • 15.4.6. Others
• 15.5. Market Value Forecast, by End-user, 2020 to 2035
  • 15.5.1. Hospitals
  • 15.5.2. Dermatology Clinics
  • 15.5.3. MedSpas
  • 15.5.4. Others
• 15.6. Market Value Forecast, by Country/Sub-region, 2020 to 2035
  • 15.6.1. GCC Countries
  • 15.6.2. South Africa
  • 15.6.3. Rest of Middle East & Africa
• 15.7. Market Attractiveness Analysis
  • 15.7.1. By Product Type
  • 15.7.2. By Gender
  • 15.7.3. By Application
  • 15.7.4. By End-user
  • 15.7.5. By Country/Sub-region

16. Competition Landscape

• 16.1. Market Player - Competition Matrix (By Tier and Size of companies)
• 16.2. Market Share Analysis, by Company (2024)
• 16.3. Company Profiles
  • 16.3.1. AbbVie Inc. (Allergan Aesthetics)
    • 16.3.1.1. Company Overview
    • 16.3.1.2. Financial Overview
    • 16.3.1.3. Product Portfolio
    • 16.3.1.4. Business Strategies
    • 16.3.1.5. Recent Developments
  • 16.3.2. Anika Therapeutics, Inc.
    • 16.3.2.1. Company Overview
    • 16.3.2.2. Financial Overview
    • 16.3.2.3. Product Portfolio
    • 16.3.2.4. Business Strategies
    • 16.3.2.5. Recent Developments
  • 16.3.3. Bioplus Co., Ltd.
    • 16.3.3.1. Company Overview
    • 16.3.3.2. Financial Overview
    • 16.3.3.3. Product Portfolio
    • 16.3.3.4. Business Strategies
    • 16.3.3.5. Recent Developments
  • 16.3.4. BIOXIS Pharmaceuticals
    • 16.3.4.1. Company Overview
    • 16.3.4.2. Financial Overview
    • 16.3.4.3. Product Portfolio
    • 16.3.4.4. Business Strategies
    • 16.3.4.5. Recent Developments
  • 16.3.5. Bloomage Biotech Co., Ltd
    • 16.3.5.1. Company Overview
    • 16.3.5.2. Financial Overview
    • 16.3.5.3. Product Portfolio
    • 16.3.5.4. Business Strategies
    • 16.3.5.5. Recent Developments
  • 16.3.6. Galderma
    • 16.3.6.1. Company Overview
    • 16.3.6.2. Financial Overview
    • 16.3.6.3. Product Portfolio
    • 16.3.6.4. Business Strategies
    • 16.3.6.5. Recent Developments
  • 16.3.7. Sinclair Pharma
    • 16.3.7.1. Company Overview
    • 16.3.7.2. Financial Overview
    • 16.3.7.3. Product Portfolio
    • 16.3.7.4. Business Strategies
    • 16.3.7.5. Recent Developments
  • 16.3.8. Revance Therapeutics, Inc.
    • 16.3.8.1. Company Overview
    • 16.3.8.2. Financial Overview
    • 16.3.8.3. Product Portfolio
    • 16.3.8.4. Business Strategies
    • 16.3.8.5. Recent Developments
  • 16.3.9. Merz Pharma GmbH & Co. KGaA
    • 16.3.9.1. Company Overview
    • 16.3.9.2. Financial Overview
    • 16.3.9.3. Product Portfolio
    • 16.3.9.4. Business Strategies
    • 16.3.9.5. Recent Developments
  • 16.3.10. Prollenium Medical Technologies Inc.
    • 16.3.10.1. Company Overview
    • 16.3.10.2. Financial Overview
    • 16.3.10.3. Product Portfolio
    • 16.3.10.4. Business Strategies
    • 16.3.10.5. Recent Developments
  • 16.3.11. Teoxane SA
    • 16.3.11.1. Company Overview
    • 16.3.11.2. Financial Overview
    • 16.3.11.3. Product Portfolio
    • 16.3.11.4. Business Strategies
    • 16.3.11.5. Recent Developments
  • 16.3.12. Croma-Pharma GmbH
    • 16.3.12.1. Company Overview
    • 16.3.12.2. Financial Overview
    • 16.3.12.3. Product Portfolio
    • 16.3.12.4. Business Strategies
    • 16.3.12.5. Recent Developments
  • 16.3.13. Fidia Pharma USA Inc.
    • 16.3.13.1. Company Overview
    • 16.3.13.2. Financial Overview
    • 16.3.13.3. Product Portfolio
    • 16.3.13.4. Business Strategies
    • 16.3.13.5. Recent Developments
  • 16.3.14. Tiger Aesthetics Medical, LLC
    • 16.3.14.1. Company Overview
    • 16.3.14.2. Financial Overview
    • 16.3.14.3. Product Portfolio
    • 16.3.14.4. Business Strategies
    • 16.3.14.5. Recent Developments